Journey Medical (DERM) Income from Non-Controlling Interests (2021 - 2022)
Journey Medical (DERM) posted Income from Non-Controlling Interests of $64000.0 for Q2 2022, down 38.46% on a QoQ basis from $104000.0 in Q1 2022, and down 98.12% year-over-year from $3.4 million in Q2 2021.
Journey Medical (DERM) Income from Non-Controlling Interests (2021 - 2022) Analysis & Trends
Journey Medical's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $64000.0 for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Jun 30, 2021 | 3.40 Mn |
| Mar 31, 2021 | 96,000.00 |